A Single Centre, Placebo-Controlled, Double-Masked, Sequential Designed Study to Evaluate 3 Ophthalmic Formulations of AMA0076 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Jun 2014
Price : $35 *
At a glance
- Drugs PHP 201 (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Pharmacokinetics
- Sponsors Amakem
- 01 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Dec 2013 New source identified and integrated: ClinicalTrials.gov record.
- 20 Nov 2013 New trial record